Skip to content

Research on Comprehensive Scheme of Chinese Medicine Intervention in Hashimoto Thyroiditis Process Based on Markov Model

Research on Comprehensive Scheme of Chinese Medicine Intervention in Hashimoto Thyroiditis Process Based on Markov Model

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041617
Enrollment
Unknown
Registered
2021-01-01
Start date
2021-01-18
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hashimoto's thyroiditis

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic criteria of Hashimoto's thyroiditis; 2. Aged between 18 and 70 years. Gender and race are not limited; 3. No obvious abnormality in liver and kidney function: ALT, AST and BUN < 3 times of normal; Cr < normal range; 4. Who have informed consent, fixed address or telephone number and can receive long-term follow-up.

Exclusion criteria

Exclusion criteria: 1. Known pregnancy, preparing for pregnancy or lactation; 2. Complications of heart, liver, kidney, brain and blood system or combined with other serious primary diseases and psychosis; 3. Can not cooperate with the laboratory examination and questionnaire during the trial.

Design outcomes

Primary

MeasureTime frame
TSH;FT3;FT4;TT3;TT4;TG-Ab;TPO-Ab;

Secondary

MeasureTime frame
TC;TG;HDL;LDL;????? Thyroid volume;TCM syndrome score;Quality of life scale score;

Countries

China

Contacts

Public ContactWei Jun-Ping

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

weijunping@126.com+86 10-88001245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026